美国药品NDC（国家药品编码）与药品说明书数据库（U.S. FDA National Drug Code DataBase）

NDC包装代码	产品NDC	产品类型	商品名	通用名	剂型	给药途径	上市日期	结束日期	市场类别	申请号	标签持有者	活性成分	规格	包装描述
43602-418-30	43602-418	HUMAN PRESCRIPTION DRUG	LEVOTHYROXINE SODIUM	levothyroxine sodium	TABLET	ORAL	20230118	N/A	ANDA	ANDA215259	Ascent Pharmaceuticals, Inc	LEVOTHYROXINE SODIUM	.05 mg/1	30 TABLET in 1 BOTTLE (43602-418-30)
43602-418-90	43602-418	HUMAN PRESCRIPTION DRUG	LEVOTHYROXINE SODIUM	levothyroxine sodium	TABLET	ORAL	20230118	N/A	ANDA	ANDA215259	Ascent Pharmaceuticals, Inc	LEVOTHYROXINE SODIUM	.05 mg/1	90 TABLET in 1 BOTTLE (43602-418-90)
43602-422-10	43602-422	HUMAN PRESCRIPTION DRUG	LEVOTHYROXINE SODIUM	levothyroxine sodium	TABLET	ORAL	20230118	N/A	ANDA	ANDA215259	Ascent Pharmaceuticals, Inc	LEVOTHYROXINE SODIUM	.112 mg/1	1000 TABLET in 1 BOTTLE (43602-422-10)
43602-422-30	43602-422	HUMAN PRESCRIPTION DRUG	LEVOTHYROXINE SODIUM	levothyroxine sodium	TABLET	ORAL	20230118	N/A	ANDA	ANDA215259	Ascent Pharmaceuticals, Inc	LEVOTHYROXINE SODIUM	.112 mg/1	30 TABLET in 1 BOTTLE (43602-422-30)
43602-422-90	43602-422	HUMAN PRESCRIPTION DRUG	LEVOTHYROXINE SODIUM	levothyroxine sodium	TABLET	ORAL	20230118	N/A	ANDA	ANDA215259	Ascent Pharmaceuticals, Inc	LEVOTHYROXINE SODIUM	.112 mg/1	90 TABLET in 1 BOTTLE (43602-422-90)
43602-426-10	43602-426	HUMAN PRESCRIPTION DRUG	LEVOTHYROXINE SODIUM	levothyroxine sodium	TABLET	ORAL	20230118	N/A	ANDA	ANDA215259	Ascent Pharmaceuticals, Inc	LEVOTHYROXINE SODIUM	.175 mg/1	1000 TABLET in 1 BOTTLE (43602-426-10)
43602-426-30	43602-426	HUMAN PRESCRIPTION DRUG	LEVOTHYROXINE SODIUM	levothyroxine sodium	TABLET	ORAL	20230118	N/A	ANDA	ANDA215259	Ascent Pharmaceuticals, Inc	LEVOTHYROXINE SODIUM	.175 mg/1	30 TABLET in 1 BOTTLE (43602-426-30)
43602-426-90	43602-426	HUMAN PRESCRIPTION DRUG	LEVOTHYROXINE SODIUM	levothyroxine sodium	TABLET	ORAL	20230118	N/A	ANDA	ANDA215259	Ascent Pharmaceuticals, Inc	LEVOTHYROXINE SODIUM	.175 mg/1	90 TABLET in 1 PACKAGE (43602-426-90)